MedPath

DNA Hypermethylation of a panel of 5 genes in urine samples as biomarker for bladder cancer diagnosis

Not Applicable
Completed
Conditions
Bladder cancer
Cancer - Bladder
Registration Number
ACTRN12620000258954
Lead Sponsor
Research Committee of Aristotle University of Thessaloniki
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
85
Inclusion Criteria

Patients group: Subjects with Bladder Cancer who are able to provide a urine sample and undergo a cystoscopy before any treatment.

Control group: Subjects without any previous or current malignancy who are able to provide a urine sample.

Exclusion Criteria

Individuals with metastasis to urinary bladder from other organs or other malignancies

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath